Loading chat...
US HB3851
Bill
Status
6/9/2025
Primary Sponsor
Johnny Olszewski
Click for details
AI Summary
-
Extends the Direct to Phase II authority for SBIR programs from 2025 to 2030, allowing small businesses to bypass Phase I and receive Phase II funding directly
-
Expands Direct to Phase II eligibility from only NIH, Department of Defense, and Department of Education to all federal agencies required to carry out SBIR programs
-
Caps Direct to Phase II awards at 10% of an agency's total SBIR funding per fiscal year, with NIH allowed up to 15%
-
Extends the Commercialization Readiness Program for civilian agencies and the Phase 0 Proof of Concept Partnership Program through fiscal year 2030
-
Extends the Commercialization Assistance Pilot Programs from September 30, 2025 to September 30, 2030
Legislative Description
SBIR/STTR Pilot Extension Act
Commerce
Last Action
Referred to the Committee on Small Business, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
6/9/2025